Kirk J. Lubick
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Kirk J. Lubick has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Abhilash I. Chiramel
Innate Immunity and Pathogenesis Section, Laboratory of Virology, Rocky Mountain Laboratories, NIAID/NIH, 903 S. 4th St, Hamilton, MT 59840, USA
1 shared publication - Amanda Robison
Department of Microbiology & Immunology, Montana State University, Bozeman, MT 59717, USA
1 shared publication - Andrew G. Ramstead
Department of Microbiology and Immunology, Montana State University, Bozeman, Montana, USA
1 shared publication Anne Blackwell
Department of Microbiology and Immunology, Montana State University, Bozeman, Montana, USA
1 shared publication- Brett Freedman
Department of Microbiology and Immunology, Montana State University, Bozeman, Montana, USA
1 shared publication - Brian H. Youseff
University of Toledo Health Science Campus, Toledo, OH, USA
1 shared publication
Latest Publications
- Open Access
TRIM5α restricts flavivirus replication by targeting the viral protease for proteasomal degradation
Tripartite motif-containing protein 5α (TRIM5α) functions as a cellular antiviral restriction factor with exquisite specificity towards the capsid lattices of retroviruses. The relative avidity of TRIM5α binding to retrovirus capsids directly impacts primate species susceptibility to infection, but the antiviral role of TRIM5α is thought limited to retroviruses. In contrast to this current understanding, here we show that both human and rhesus TRIM5α possess potent antiviral function against specific flaviviruses through interaction with the viral protease (NS2B/3) to inhibit virus replication. Importantly, TRIM5α was essential for the antiviral function of IFN-I against sensitive flaviviruses in human cells. However, TRIM5α was ineffective against mosquito-borne flaviviruses (yellow fever, dengue, and Zika viruses) that establish transmission cycles in humans following emergence from non-human primates. Thus, TRIM5α is revealed to possess remarkable plasticity in recognition of diverse virus families, with potential to influence human susceptibility to emerging flaviviruses of global concern.
Open AccessTRIM5α restricts flavivirus replication by targeting the viral protease for proteasomal degradation
Tripartite motif-containing protein 5α (TRIM5α) functions as a cellular antiviral restriction factor with exquisite specificity towards the capsid lattices of retroviruses. The relative avidity of TRIM5α binding to retrovirus capsids directly impacts primate species susceptibility to infection, but the antiviral role of TRIM5α is thought limited to retroviruses. In contrast to this current understanding, here we show that both human and rhesus TRIM5α possess potent antiviral function against specific flaviviruses through interaction with the viral protease (NS2B/3) to inhibit virus replication. Importantly, TRIM5α was essential for the antiviral function of IFN-I against sensitive flaviviruses in human cells. However, TRIM5α was ineffective against mosquito-borne flaviviruses (yellow fever, dengue, and Zika viruses) that establish transmission cycles in humans following emergence from non-human primates. Thus, TRIM5α is revealed to possess remarkable plasticity in recognition of diverse virus families, with potential to influence human susceptibility to emerging flaviviruses of global concern.
- 1 April 2016
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 84 (4) , 940-949
Roles of Toll-Like Receptor 2 (TLR2), TLR4, and MyD88 during Pulmonary Coxiella burnetii Infection
Coxiella burnetii, the causative agent of Q fever, is an obligate intracellular primarily pulmonary bacterial pathogen. Though much is known about adaptive immune responses against this bacterium, our understanding of innate immune responses against C. burnetii are not well defined, particularly within the target tissue for infection - the lung. Previous studies examined the roles of the innate immune system receptors, TLR2 and TLR4, in peripheral infection models and described minimal phenotypes in specific gene deletion animals compared to their wildtype controls. Here, we assessed the roles for TLR2, TLR4, and MyD88 in pulmonary C. burnetii infection and compared responses to those that occurred in TLR2 and TLR4 deficient animals following peripheral infection. As observed previously, neither TLR2 nor TLR4 were needed for limiting bacterial growth after peripheral infection. In contrast, TLR2 and to a lesser extent TLR4 limited growth (or dissemination) of the bacterium in the lung and spleen after pulmonary infection. TLR2, TLR4, or MyD88 were not required for the general inflammatory response in the lungs after pulmonary infection. However, MyD88 signaling was important for infection-induced morbidity. Finally, TLR2 expression on hematopoietic cells was most important for limiting bacterial growth in the lung. These results expand on our knowledge of the roles for TLR2 and TLR4 in C. burnetii infection and suggest varying roles for these receptors that are dictated by the site of infection.
- 1 April 2016
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 84 (4) , 940-949
Roles of Toll-Like Receptor 2 (TLR2), TLR4, and MyD88 during Pulmonary Coxiella burnetii Infection
Coxiella burnetii, the causative agent of Q fever, is an obligate intracellular primarily pulmonary bacterial pathogen. Though much is known about adaptive immune responses against this bacterium, our understanding of innate immune responses against C. burnetii are not well defined, particularly within the target tissue for infection - the lung. Previous studies examined the roles of the innate immune system receptors, TLR2 and TLR4, in peripheral infection models and described minimal phenotypes in specific gene deletion animals compared to their wildtype controls. Here, we assessed the roles for TLR2, TLR4, and MyD88 in pulmonary C. burnetii infection and compared responses to those that occurred in TLR2 and TLR4 deficient animals following peripheral infection. As observed previously, neither TLR2 nor TLR4 were needed for limiting bacterial growth after peripheral infection. In contrast, TLR2 and to a lesser extent TLR4 limited growth (or dissemination) of the bacterium in the lung and spleen after pulmonary infection. TLR2, TLR4, or MyD88 were not required for the general inflammatory response in the lungs after pulmonary infection. However, MyD88 signaling was important for infection-induced morbidity. Finally, TLR2 expression on hematopoietic cells was most important for limiting bacterial growth in the lung. These results expand on our knowledge of the roles for TLR2 and TLR4 in C. burnetii infection and suggest varying roles for these receptors that are dictated by the site of infection.